We’ve Got You Covered
The CBD landscape in the UK just changed — but if you’re working with Mile High Labs, your brand is already ahead.
In July 2025, the Food Standards Agency (FSA) rolled out critical updates to its CBD business guidance — including a provisional Acceptable Daily Intake (ADI) of 10 mg CBD/day, a Safe Upper Limit of 0.07 mg THC/day, and new permissions for companies to reformulate and update products listed on the CBD Public List. For brands and manufacturers scrambling to keep pace, the pressure is on. But at Mile High Labs, we built for this moment years ago.
👉 We’ve got you covered.
🔑What’s Changing in UK CBD Regulation?
According to the FSA’s official CBD guidance, products on the UK market must now align with:
- 10 mg/day CBD intake for healthy adults
- 0.07 mg/day THC (1 µg/kg bodyweight/day)
- Ongoing 1 mg THC per container limit (per Home Office rule)
And if your products are on the CBD Public List, you’re expected to reformulate for safety, update labels with consumer warnings, and prepare for the first wave of official product authorisations.
For many companies, this means reformulation chaos.
For Mile High Labs, it’s just another proof point that we were built for regulated markets.
🏆Why Mile High Labs Leads — And Why That Matters to You
We didn’t wait for regulators to set the bar.
We raised it ourselves.
- CBD Isolate 2.0: Launched in 2022, engineered to eliminate all detectable THC variants (Δ9-THC, Δ8-THC, THCA) — not in response to enforcement, but in anticipation of it.
- Published FSA Safety Assessment: Among the highest ADI ratings across Group A applicants.
- 12 Fully Validated End-Use Categories: Including chewing gum, chocolate products, confectionery, flavoured drinks, fruit juices, honey, CBD-infused water, capsules, tablets, liquids, syrups, and chewable forms — more end-use categories than any other company currently on the Public List, where competitors typically offer only 1–3.
- Direct Manufacturing Control: We own our supply chain, control our production, and deliver zero disruption for partners.
While others share regulatory risk, we eliminate it — giving your brand peace of mind, resilience, and a decisive competitive edge.
🚀Reformulation? Relabeling? Innovation? With Mile High Labs, You’re Already Compliant — And Ready to Lead
With the FSA now permitting limited reformulation and supplier changes for products on the CBD Public List, many brands are wondering:
- Do we need to reformulate?
- Can we meet the new ADI + THC limits?
- Will we have to pull products or update labels?
If you’re with Mile High Labs, the answer is simple:
✅ You’re already aligned.
✅ You’re already supported.
✅ You’re already protected.
⚡Why Now Is the Time to Innovate
Now isn’t just the time to react — it’s the time to innovate.
✔️ Start R&D and formulation work.
✔️ Expand your product portfolio and SKUs.
✔️ Prepare stability and market testing.
✔️ Get ready to be first to shelf when authorisation arrives.
Mile High Labs is your one-stop partner to move from compliance to category leadership.
🌍 Leading the Way, Together
We believe regulatory alignment isn’t just a checkbox — it’s a commitment to consumer safety, product integrity, and long-term brand success.
As the industry moves toward stronger compliance and collaboration, Mile High Labs stands out as the only CBD partner offering compliant ingredients across 12 validated end-use categories — unmatched by any other supplier on the Public List.
Don’t just keep up. Lead the market.
Discover how our CBD Isolate 2.0 and water-soluble CBD solutions are already built for success.
💬 Ready to Future-Proof Your Brand?
The CBD market is evolving fast. With Mile High Labs, you’re not just surviving the shift — you’re thriving in it.
✅ Turnkey compliance across 12 validated end-use categories
✅ Published safety dossier + top-tier regulatory status
✅ Global manufacturing excellence
✅ Unmatched technical and customer support
👉 Talk to our sales team today to lock in your compliant ingredient supply before competitors do.
⚡ Don’t Wait — Get Ahead Before Authorisations Roll Out
We’re helping partners across the UK, EU, and Japan secure regulatory-ready products now — before the next wave of authorisations changes the market.
✅ Avoid reformulation chaos.
✅ Protect your shelf space.
✅ Accelerate your go-to-market plans.
📩 Contact our sales team now — let’s build your next success story.
👉 Learn more and explore the full CBD Public List here: CBD Public List
👉 Understand the latest FSA updates here: FSA CBD Business Guidance
👉 See how industry leaders are shaping the future: Cannabis Trades Association Article
